Legal Affairs

Clearmind Featured in Bipartisan Veterans Therapy Bill

WASHINGTON D.C. – The recent introduction of bipartisan legislation in the U.S. House of Representatives has drawn attention to Clearmind Medicine Inc.'s proprietary compound MEAI as part of efforts to broaden veterans' access to certain ...

Fluent Offloads Pennsylvania Dispensaries

NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...

DEA Increases Psychedelics Production Quotas for 2026

WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...

Clearmind Featured in Bipartisan Veterans Therapy Bill

WASHINGTON D.C. – The recent introduction of bipartisan legislation in the U.S. House of Representatives has drawn attention to Clearmind Medicine Inc.'s proprietary compound MEAI as part of efforts to broaden veterans' access to certain ...

Medical Cannabis: Growth and Investment in 2024

LOS ANGELES- The medical cannabis industry is navigating 2024 with key players like Grow Group and Somai Pharmaceuticals leveraging new regulations and market dynamics to achieve ambitious growth targets. This article examines the recent developments ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal ...

Critics Slam Thai Government’s Approach to Cannabis

LOS ANGELES- Critics have strongly opposed the Thai government's plan to reclassify cannabis as a narcotic, arguing that it will harm businesses involved in cannabis-based products and undermine investor confidence in the country. On July ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands,  maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal year 2025 ...

Subscribe To Our Newsletter